HSV-1 viremia as a potential cause of febrile neutropenia in an immunocompromised child.
Although the standard of care in febrile neutropenic patients includes the initiation of empirical antibacterial and antifungal therapy, many patients do not respond and need further diagnostic work up and treatment. Here, we report on an immunosuppressed neutropenic patient with a prolonged episode of fever unresponsive to empirical antibacterial therapy. Herpes polymerase chain reaction revealed systemic reactivation of herpes simplex virus type 1 (HSV-1) infection and treatment with acyclovir was associated with the prompt resolution of signs and symptoms of infection. Screening for HSV in persistently febrile neutropenic patients may discover HSV reactivation that can be treated successfully by acyclovir administration.
Holzinger
Dirk
D
Department of Pediatric Hematology/Oncology, Institute of Immunology, University Hospital Muenster, Center for Bone Marrow Transplantation, University Children's Hospital Muenster, Muenster, Germany.
Kühn
Joachim
J
Ehlert
Karoline
K
Groll
Andreas H
AH
D000212:Acyclovir / Q000627:therapeutic use; D002648:Child; D005334:Fever / Q000209:etiology; D006561:Herpes Simplex / Q000188:drug therapy; D018259:Herpesvirus 1, Human / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009503:Neutropenia / Q000209:etiology*; D014766:Viremia / Q000150:complications*; D014775:Virus Activation
D007166:Immunosuppressive Agents; D000212:Acyclovir